Chelsea Counsel Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.46M Sell
18,241
-3,303
-15% -$769K 1.98% 14
2025
Q4
$4.46M Sell
21,544
-116
-0.5% -$22.9K 1.91% 14
2025
Q3
$4.02M Hold
21,660
1.78% 14
2025
Q2
$3.31M Sell
21,660
-220
-1% -$33.8K 1.64% 17
2025
Q1
$3.63M Hold
21,880
1.97% 13
2024
Q4
$3.16M Sell
21,880
-1,744
-7% -$270K 1.63% 16
2024
Q3
$3.83M Sell
23,624
-1,061
-4% -$169K 1.89% 14
2024
Q2
$3.61M Sell
24,685
-263
-1% -$39.1K 1.8% 14
2024
Q1
$3.95M Sell
24,948
-1,806
-7% -$287K 2.24% 12
2023
Q4
$4.19M Sell
26,754
-1,617
-6% -$248K 2.22% 12
2023
Q3
$4.42M Sell
28,371
-10,295
-27% -$1.7M 2.27% 11
2023
Q2
$6.4M Sell
38,666
-252
-0.6% -$40.7K 3.15% 9
2023
Q1
$6.03M Sell
38,918
-500
-1% -$80.7K 2.93% 9
2022
Q4
$6.96M Sell
39,418
-1,850
-4% -$319K 3.48% 5
2022
Q3
$6.74M Sell
41,268
-3,635
-8% -$615K 4.16% 4
2022
Q2
$7.97M Sell
44,903
-505
-1% -$90K 4.1% 5
2022
Q1
$8.05M Sell
45,408
-343
-0.7% -$58.4K 3.55% 8
2021
Q4
$7.83M Sell
45,751
-255
-0.6% -$41.7K 3.39% 8
2021
Q3
$7.43M Buy
46,006
+740
+2% +$126K 3.38% 8
2021
Q2
$7.46M Buy
45,266
+2,505
+6% +$415K 3.44% 6
2021
Q1
$7.03M Sell
42,761
-189
-0.4% -$30.6K 3.48% 6
2020
Q4
$6.76M Sell
42,950
-1,268
-3% -$187K 3.48% 6
2020
Q3
$6.58M Sell
44,218
-1,795
-4% -$266K 3.89% 6
2020
Q2
$6.47M Buy
46,013
+1,120
+2% +$163K 3.99% 6
2020
Q1
$5.89M Sell
44,893
-451
-1% -$64K 4.62% 4
2019
Q4
$6.61M Sell
45,344
-1,960
-4% -$266K 4.02% 5
2019
Q3
$6.12M Sell
47,304
-7,002
-13% -$922K 3.68% 7
2019
Q2
$7.56M Sell
54,306
-98
-0.2% -$13.6K 4.05% 8
2019
Q1
$7.61M Sell
54,404
-1,904
-3% -$255K 4.1% 7
2018
Q4
$7.27M Buy
56,308
+51
+0.1% +$7.11K 4.41% 6
2018
Q3
$7.77M Buy
56,257
+4,169
+8% +$554K 4.05% 7
2018
Q2
$6.32M Sell
52,088
-8,374
-14% -$1.04M 3.76% 7
2018
Q1
$7.75M Sell
60,462
-8,391
-12% -$1.13M 4.98% 6
2017
Q4
$9.62M Sell
68,853
-9,535
-12% -$1.33M 5.14% 3
2017
Q3
$10.2M Sell
78,388
-947
-1% -$126K 5.1% 3
2017
Q2
$10.5M Buy
79,335
+1,021
+1% +$130K 5.46% 3
2017
Q1
$9.75M Buy
78,314
+75
+0.1% +$8.96K 5.01% 4
2016
Q4
$9.01M Buy
78,239
+91
+0.1% +$10.5K 4.74% 4
2016
Q3
$9.23M Sell
78,148
-704
-0.9% -$85.4K 4.72% 4
2016
Q2
$9.56M Sell
78,852
-22,666
-22% -$2.58M 4.32% 4
2016
Q1
$11M Sell
101,518
-1,835
-2% -$190K 3.54% 4
2015
Q4
$10.6M Sell
103,353
-78,577
-43% -$7.9M 3.2% 6
2015
Q3
$17M Sell
181,930
-1,000
-0.5% -$96.7K 4.04% 4
2015
Q2
$17.8M Sell
182,930
-1,109
-0.6% -$111K 3.99% 3
2015
Q1
$18.5M Buy
184,039
+296
+0.2% +$30.1K 3.99% 5
2014
Q4
$19.2M Sell
183,743
-1,066
-0.6% -$112K 3.95% 4
2014
Q3
$19.7M Buy
184,809
+2,207
+1% +$229K 3.93% 3
2014
Q2
$19.1M Buy
182,602
+510
+0.3% +$51.5K 3.73% 3
2014
Q1
$17.9M Buy
182,092
+35,746
+24% +$3.31M 3.63% 4
2013
Q4
$13.4M Sell
146,346
-32,510
-18% -$3M 3.17% 7
2013
Q3
$15.5M Buy
178,856
+30,517
+21% +$2.74M 3.21% 8
2013
Q2
$12.7M Buy
+148,339
New +$12.6M 3.34% 6

Other funds holding JNJ

Chelsea Counsel Company's JNJ Position: Q1 2026 in Review

Chelsea Counsel Company reduced its Johnson & Johnson (JNJ) stake by 15% in Q1 2026, selling an estimated $769K and leaving 18,241 shares worth $4.46M. The position accounts for 1.98% of the portfolio, ranked #14.

Chelsea Counsel Company first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.7M in Q3 2014. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Chelsea Counsel Company held 18,241 shares of Johnson & Johnson worth $4.46M as of Q1 2026.
  • Chelsea Counsel Company sold 3,303 Johnson & Johnson shares in Q1 2026, an estimated $769K.
  • Johnson & Johnson made up 1.98% of Chelsea Counsel Company's portfolio in Q1 2026, its #14 holding.
  • Chelsea Counsel Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Chelsea Counsel Company's Johnson & Johnson position peaked at $19.7M in Q3 2014.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.